Literature DB >> 15044588

Synergy between signal transducer and activator of transcription 3 and retinoic acid receptor-alpha in regulation of the surfactant protein B gene in the lung.

Li Yang1, Xuemei Lian, Angelynn Cowen, Huan Xu, Hong Du, Cong Yan.   

Abstract

During respiratory cycles, airborne particles and pathogens are inhaled into the lung, which can cause cytokine production by respiratory macrophages and inflammatory responses. Secreted cytokines affect surfactant protein expression and homeostasis in the lung. In coculturing experiments in vitro, bronchoalveolar macrophages stimulated human surfactant protein B (hSP-B) gene transcription in primary alveolar type II epithelial cells in lipopolysaccharide-independent and -dependent ways. Neutralization by IL-6 antibody abolished lipopolysaccharide-dependent macrophage stimulation of hSP-B gene transcription. IL-6 treatment enhanced signal transducer and activator of transcription (Stat)3 phosphorylation at Y705 in alveolar type II epithelial cells and Clara cells in vivo. Biochemical analysis of functional domain swapping between Stat1 and Stat3 identified that the SH2 domain and the DNA binding domain are critical for Stat3 stimulation of hSP-B gene transcription. Glutathione-S-transferase pull-down study determined functional domains required for protein-protein interaction between Stat3 and retinoic acid receptor-alpha. Cotransfection of Stat3 and retinoic acid receptor-alpha into respiratory epithelial cells resulted in synergistic DNA binding and transcriptional activation on the hSP-B gene. To assess Stat3 physiological function, overexpression of a dominant negative Stat3 in respiratory epithelial cells in a doxycycline-controlled double transgenic mouse line caused pulmonary emphysema and increase of animal death during hyperoxia. Therefore, the IL-6/Stat3 signaling axis plays an important role in surfactant protein homeostasis and respiratory inflammation in the lung.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15044588     DOI: 10.1210/me.2003-0458

Source DB:  PubMed          Journal:  Mol Endocrinol        ISSN: 0888-8809


  14 in total

1.  JAK-STAT signaling regulation of chicken embryonic stem cell differentiation into male germ cells.

Authors:  Yu Zhang; Lei Zhang; Qisheng Zuo; Yinjie Wang; Yani Zhang; Qi Xu; Bichun Li; Guohong Chen
Journal:  In Vitro Cell Dev Biol Anim       Date:  2017-06-08       Impact factor: 2.416

2.  Matrix metalloproteinase 12 overexpression in myeloid lineage cells plays a key role in modulating myelopoiesis, immune suppression, and lung tumorigenesis.

Authors:  Peng Qu; Cong Yan; Hong Du
Journal:  Blood       Date:  2011-03-04       Impact factor: 22.113

3.  NLRP3 protein deficiency exacerbates hyperoxia-induced lethality through Stat3 protein signaling independent of interleukin-1β.

Authors:  Yoshiko Mizushina; Koumei Shirasuna; Fumitake Usui; Tadayoshi Karasawa; Akira Kawashima; Hiroaki Kimura; Motoi Kobayashi; Takanori Komada; Yoshiyuki Inoue; Naoko Mato; Hideaki Yamasawa; Eicke Latz; Yoichiro Iwakura; Tadashi Kasahara; Masashi Bando; Yukihiko Sugiyama; Masafumi Takahashi
Journal:  J Biol Chem       Date:  2014-12-29       Impact factor: 5.157

4.  Glucocorticoids potentiate IL-6-induced SP-B expression in H441 cells by enhancing the JAK-STAT signaling pathway.

Authors:  Andreas Ladenburger; Matthias Seehase; Boris W Kramer; Wolfgang Thomas; Johannes Wirbelauer; Christian P Speer; Steffen Kunzmann
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2010-08-06       Impact factor: 5.464

5.  LPS-treated macrophage cytokines repress surfactant protein-B in lung epithelial cells.

Authors:  Kiflai Bein; Michelangelo Di Giuseppe; Steven E Mischler; Luis A Ortiz; George D Leikauf
Journal:  Am J Respir Cell Mol Biol       Date:  2013-08       Impact factor: 6.914

6.  RARalpha2 expression is associated with disease progression and plays a crucial role in efficacy of ATRA treatment in myeloma.

Authors:  Siqing Wang; Guido Tricot; Lei Shi; Wei Xiong; Zhaoyang Zeng; Hongwei Xu; Maurizio Zangari; Bart Barlogie; John D Shaughnessy; Fenghuang Zhan
Journal:  Blood       Date:  2009-05-20       Impact factor: 22.113

7.  Stat3 downstream genes serve as biomarkers in human lung carcinomas and chronic obstructive pulmonary disease.

Authors:  Peng Qu; Jennifer Roberts; Yuan Li; Marjorie Albrecht; Oscar W Cummings; John N Eble; Hong Du; Cong Yan
Journal:  Lung Cancer       Date:  2008-07-09       Impact factor: 5.705

Review 8.  Targeting Janus Kinases and Signal Transducer and Activator of Transcription 3 to Treat Inflammation, Fibrosis, and Cancer: Rationale, Progress, and Caution.

Authors:  Uddalak Bharadwaj; Moses M Kasembeli; Prema Robinson; David J Tweardy
Journal:  Pharmacol Rev       Date:  2020-04       Impact factor: 25.468

9.  Gene induction during differentiation of human pulmonary type II cells in vitro.

Authors:  Kelly C Wade; Susan H Guttentag; Linda W Gonzales; Kathryn L Maschhoff; John Gonzales; Venkatadri Kolla; Sunil Singhal; Philip L Ballard
Journal:  Am J Respir Cell Mol Biol       Date:  2006-02-10       Impact factor: 6.914

10.  Stable expression of constitutively-activated STAT3 in benign prostatic epithelial cells changes their phenotype to that resembling malignant cells.

Authors:  Hosea F Huang; Thomas F Murphy; Ping Shu; Arnold B Barton; Beverly E Barton
Journal:  Mol Cancer       Date:  2005-01-12       Impact factor: 27.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.